Literature DB >> 16491099

Cholecystokinin 1 receptor modulates the MEKK1-induced c-Jun trans-activation: structural requirements of the receptor.

Géraldine Ibarz1, Catherine Oiry, Eric Carnazzi, Philippe Crespy, Chantal Escrieut, Daniel Fourmy, Jean Claude Galleyrand, Didier Gagne, Jean Martinez.   

Abstract

In cells overexpressing active MEKK1 to enhance c-Jun trans-activation, expression of rat cholecystokinin 1 receptor increased the activity of c-Jun while in the same experimental conditions overexpression of mouse cholecystokinin 1 receptor repressed it. This differential trans-activation is specific, since it was not observed for either the other overexpressed kinases (MEK, PKA) or for other transcription factors (ATF2, ELK-1, CREB). This differential behaviour was also detected in a human colon adenocarcinoma cell-line naturally producing high levels of endogenous MEKK1. This differential behaviour between the two receptors on the MEKK1-induced c-Jun trans-activation was independent of the activation state of JNK, of the phosphorylation level of c-Jun and of its ability to bind its specific DNA responsive elements. Two amino acids (Val43 and Phe50 in the mouse cholecystokinin 1 receptor, replaced by Leu43 and Ileu50 in the rat cholecystokinin 1 receptor) localized in the first transmembrane domain were found to play a crucial role in this differential behaviour. MEKK1 probably activates a transcriptional partner of c-Jun whose activity is maintained or increased in the presence of the rat cholecystokinin 1 receptor but repressed in the presence of the mouse cholecystokinin 1 receptor.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16491099      PMCID: PMC1760718          DOI: 10.1038/sj.bjp.0706690

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  34 in total

Review 1.  CREB-binding protein and p300 in transcriptional regulation.

Authors:  N Vo; R H Goodman
Journal:  J Biol Chem       Date:  2001-03-08       Impact factor: 5.157

Review 2.  Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity.

Authors:  Y Chinenov; T K Kerppola
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

3.  Stimulation of p300-mediated transcription by the kinase MEKK1.

Authors:  R H See; D Calvo; Y Shi; H Kawa; M P Luke; Z Yuan; Y Shi
Journal:  J Biol Chem       Date:  2001-02-22       Impact factor: 5.157

4.  The third intracellular loop of the rat and mouse cholecystokinin-A receptors is responsible for different patterns of gene activation.

Authors:  R Poosti; L di Malta; D Gagne; N Bernad; J C Galleyrand; C Escrieut; S Silvente-Poirot; D Fourmy; J Martinez
Journal:  Mol Pharmacol       Date:  2000-12       Impact factor: 4.436

Review 5.  Molecular tinkering of G protein-coupled receptors: an evolutionary success.

Authors:  J Bockaert; J P Pin
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

6.  Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin.

Authors:  V Gigoux; B Maigret; C Escrieut; S Silvente-Poirot; M Bouisson; J A Fehrentz; L Moroder; D Gully; J Martinez; N Vaysse; A D Fourmy
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

7.  Species differences between rat and mouse CCKA receptors determine the divergent acinar cell response to the cholecystokinin analog JMV-180.

Authors:  B Ji; A S Kopin; C D Logsdon
Journal:  J Biol Chem       Date:  2000-06-23       Impact factor: 5.157

Review 8.  Jun, the oncoprotein.

Authors:  P K Vogt
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

9.  Molecular complex of cholecystokinin-8 and N-terminus of the cholecystokinin A receptor by NMR spectroscopy.

Authors:  M Pellegrini; D F Mierke
Journal:  Biochemistry       Date:  1999-11-09       Impact factor: 3.162

10.  K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression.

Authors:  S Guerrero; I Casanova; L Farré; A Mazo; G Capellà; R Mangues
Journal:  Cancer Res       Date:  2000-12-01       Impact factor: 12.701

View more
  1 in total

1.  Transcriptional regulation of monocyte chemotactic protein-1 release by endothelin-1 in human airway smooth muscle cells involves NF-kappaB and AP-1.

Authors:  Amy M Sutcliffe; Deborah L Clarke; Dawn A Bradbury; Lisa M Corbett; Jamie A Patel; Alan J Knox
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.